Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery
Online ISSN : 2758-8777
Print ISSN : 2186-9545
Everolomus, new target drug for mTOR in the field of breast cancer treatment
Norikazu Masuda
Author information
Keywords: advanced/metastatic breast cancer, hormone resistance, everolimus, mTOR, PI3K/AKT pathway
JOURNAL FREE ACCESS FULL-TEXT HTML

2015 Volume 32 Issue 2 Pages 80-85

Details
Full-text HTML Download PDF (1862K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
[in Japanese]
Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc/4.0/deed.ja
Previous article Next article
Favorites & Alerts

Recently viewed articles
Successor

Official Journal of the Japan Association of Endocrine Surgery

Share this page
feedback
 Top